Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02699593 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of Approved Contact Lenses

A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
142
Enrollment target
7
Study locations

NCT02699593 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 142 participants, roughly in line with the 133-participant average among 20 other Visual Acuity trials with a reported enrollment target. The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02699593, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
142 participants
Enrollment target
7
Study locations

Study Summary

This is a 4-week, randomized, double-masked study where subjects will wear bilaterally test and control lenses in random succession. The objective is to evaluate materials from different suppliers.

Conditions Studied

Interventions

  • DEVICE Test Contact Lens
  • DEVICE Control Contact Lens

Study Locations (7)

Florida

  • Eye Elements Eyecare - Jacksonville
  • Golden Vision - Sarasota

Alabama

  • University of Alabama at Birmingham - Birmingham

Kansas

  • Advantage Eyecare Associates, LLC - Neodesha

Missouri

  • Advanced Eyecare, PC - Raytown

Ohio

  • Professional Vision Care - Westerville

Virginia

  • Timothy R. Poling, OD - Roanoke

Trial Details

FieldValue
Enrollment Target 142 participants
Start Date 2016-02-01
Est. Completion 2016-04-01
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT02699593

The ClinicalTrials.gov registry entry for NCT02699593 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 133-participant average among 20 other Visual Acuity trials with a reported enrollment target. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which Test Contact Lens is the first listed.

NCT02699593 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Florida, Alabama, Kansas.

Frequently Asked Questions

What is clinical trial NCT02699593 about?

NCT02699593 is a clinical study titled "Clinical Evaluation of Approved Contact Lenses". This is a 4-week, randomized, double-masked study where subjects will wear bilaterally test and control lenses in random succession. The objective is to evaluate materials from different suppliers.

What is the current status of trial NCT02699593?

This trial is currently completed. It is a NA study. The enrollment target is 142 participants. The study started on 2016-02-01. Estimated completion is 2016-04-01.

What conditions does trial NCT02699593 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT02699593?

The interventions under investigation include: Test Contact Lens (DEVICE), Control Contact Lens (DEVICE).

Who is sponsoring clinical trial NCT02699593?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02699593 being conducted?

This trial has 7 study locations across Alabama, Florida, Kansas, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.